Skip to content

SPRINT HEART: Study of Progressive Resistance and INterval Training in HEART disease

SPRINT HEART: Study to evaluate the effect of Progressive Resistance and INterval Training on aerobic capacity and muscular strength in patients with coronary HEART disease: A Randomised Controlled Trial of Novel Exercise Prescription in Cardiac Rehabilitation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12617001393347
Acronym
SPRINT HEART
Enrollment
0
Registered
2017-10-03
Start date
2018-04-09
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Study of Progressive Resistance and INterval Training in coronary HEART disease (SPRINT HEART) is a 12-week, single blind, randomised controlled trial with a control group crossover. Participants will be randomised to either high intensity aerobic interval training (HIIT), high intensity resistance training (PRT) or usual medical care (control). The key aims of this investigation are to directly compare high-intensity aerobic and resistance training in terms of relevant physiological adaptations, fitness, safety and feasibility in a cardiac rehabilitation cohort.

Interventions

Eligible and consenting patients will be allocated to one of three study arms; high-intensity progressive-resistance training (PRT), high-intensity aerobic interval training (HIT) or standard medical care (SMC, control). The intervention period is 12 weeks in duration and training will be 3 times per week for approximately 60 minutes at the Faculty of Health Sciences Cumberland campus (Lidcombe). Training will be supervised by a postgraduate exercise physiology student, and initial sessions wi

Eligible and consenting patients will be allocated to one of three study arms; high-intensity progressive-resistance training (PRT), high-intensity aerobic interval training (HIT) or standard medical care (SMC, control). The intervention period is 12 weeks in duration and training will be 3 times per week for approximately 60 minutes at the Faculty of Health Sciences Cumberland campus (Lidcombe). Training will be supervised by a postgraduate exercise physiology student, and initial sessions will also be supervised by the study physician. Session adherence and compliance to the exercise prescription will also be monitored and recorded by the postgraduate exercise physiology student. Participants will be contacted following any missed sessions, to encourage their attendance at subsequent training sessions. Progressive-resistance training: Week 1 of the intervention will include familiarisation and gradual increase in target intensity from 50, 60, 70% 1RM in each successive session. From the first session of week 2, training intensity will be set at 80% 1RM and progressed by a projected gain in strength of 3% 1RM each session, used in conjuction with Borg RPE Scale to maintain intensity at 80% 1RM. At the start of every 7th session, 1RM will be re-tested and target weight at 80% 1RM will be recalculated based on the new 1RM. Total training volume is 24 repetitions per exercise, set initially at 3 sets of 8 repetitions. However, as intensity is most important, sets and repetitions may be manipulated such that prescribed intensity is adhered to and the total volume remains 24 repetitions per exercise. Seven pneumatic resistance machines will be used and exercises will be completed in the following order; leg press, seated row, knee extension, chest press, knee flexion, tricep pushdown, hip abduction. Participants will be instructed to contract concentrically ‘as fast as possible’ and then 3-4 seconds of control through the eccentric phase. There will be 20-30 seconds of rest between repetitions and 3-5 minutes rest between sets to allow sufficient recovery of anaerobic metabolism. Aerobic interval training: Interval training will employ the 4x4 method, as used previously in cardiac populations (Moholdt et al. 2009). The protocol consists of 8 minutes of warm up working up to 70% peak heart rate (HRpeak), followed by four 4-minute intervals at a target of 85-95% HRpeak, each separated by 3 minutes of active recovery at ~70% HRpeak. During each of the 4-minute intervals, participants will progress from 70-80% HRpeak over the first 2-minutes, to that target intensity of 85-95% HRpeak for the final 2-minutes of each interval. Following the last interval, the participant will cool down to a slow walk with no gradient for a minimum of 5 minutes, or until breathlessness has ceased. Week 1 will serve as a familiarisation period, where the time spend at the target intensity will be increased from 30, 60, 90sec. Training will take place on a treadmill, at a self-selected brisk walking or running speed, with incline adjusted for intensity. Heart rate and oxygen saturation will be continuously monitored throughout each session and rate of perceived exertion [RPE] will be recorded in the last 15 seconds of every minute of training.

Sponsors

Westmead Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• A recent Non-STEMI and/ or cardiac angioplasty, stent, or bypass (<4 wks) • Free of musculoskeletal disease, neurological process or injury that would preclude planned exercise testing or training over the long term or permanently • Able to commit to 12wks of 3/wk training at USYD • Cognitively capable of informed consent and adherence to intervention prescription

Exclusion criteria

• Unstable cardiac diagnosis (e.g. malignant arrhythmia such as VTach, crescendo or resting angina, significant or progressive valvular heart disease, etc) • Unrepaired known aortic or other aneurysm • Ejection fraction <30% , c/w HFREF diagnosis, or NYHA CLASS III or IV CHF • Exercise treadmill stress test severely limited by condition other than aerobic capacity (e.g., OA, PAD) – • Hisotry of recurrent stroke or TIAs (2 or more) • Diagnosed cognitive or progressive neurodegenerative disorder (e.g. dementia, Parkinson's Disease, MS, etc.) • Presence of any other disease or chronic condition that study physician deems may permanently impede safe exercise completion • Presence of alcoholism, assessed by CAGE questionnaire and reported alcohol intake above NHMRC safe levels • Current psychosis or suicidality Participants may be deemed 'On Hold' and require further medical advice if they meet one of the following conditions: • Angioplasty or. stenting (~6 wks post) • Open heart surgery – sternum recovery (~12 wks post) • New diagnostic finding on exercise stress test that will require specialist referral for further evaluation and follow up, including heart block, atrial fibrillation/flutter, new ST changes or q waves or other significant change in resting or exercise ECG • New or Unstable acute or chronic disease or injury such as diabetes, COPD, hernia, rotator cuff disease, until stabilised or further evaluated

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026